Clinical Trial Update: Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of ibrutinib with methotrexate and temozolomide for newly diagnosed primary central nervous system lymphoma (P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Non-hodgkin Lymphoma
• Pcnsl

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Temozolomide (Temozolomide)
• ibrutinib (brand/generic not specified) (ibrutinib)

Snippet

Sponsor: Huiqiang Huang | Conditions: Primary Central Nervous System Lymphoma, PCNSL | Phase 2 | Status: UNKNOWN